Switch theme
Sign up to access all valuation multiples
Genky Drug Stores Co Ltd sells beauty and pharmaceutical products.
1990
2.8K+
LTM Revenue $1.3B
LTM EBITDA n/a
$769M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Genky Drug Stores has a last 12-month revenue of $1.3B and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Genky Drug Stores achieved revenue of $1.2B and an EBITDA of $96.2M.
Genky Drug Stores expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Genky Drug Stores valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | XXX | XXX | XXX |
| Gross Profit | $206M | $230M | XXX | XXX | XXX |
| Gross Margin | 18% | 19% | XXX | XXX | XXX |
| EBITDA | $77.9M | $96.2M | XXX | XXX | XXX |
| EBITDA Margin | 7% | 8% | XXX | XXX | XXX |
| Net Profit | $29.4M | $31.7M | XXX | XXX | XXX |
| Net Margin | 3% | 3% | XXX | XXX | XXX |
| Net Debt | $169M | $179M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Genky Drug Stores's stock price is JPY 2954 (or $20).
Genky Drug Stores has current market cap of JPY 89.8B (or $597M), and EV of JPY 116B (or $769M).
See Genky Drug Stores trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $769M | $597M | XXX | XXX | XXX | XXX | $1.49 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Genky Drug Stores has market cap of $597M and EV of $769M.
Genky Drug Stores's trades at 0.6x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Genky Drug Stores's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Genky Drug Stores and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $769M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.6x | XXX | XXX | XXX |
| P/E | 13.5x | XXX | XXX | XXX |
| P/E/Growth | 1.1x | XXX | XXX | XXX |
| EV/FCF | 825.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpGenky Drug Stores's NTM/LTM revenue growth is 11%
Genky Drug Stores's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Genky Drug Stores's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Genky Drug Stores's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Genky Drug Stores and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 23% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 18% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 15% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Genky Drug Stores acquired XXX companies to date.
Last acquisition by Genky Drug Stores was XXXXXXXX, XXXXX XXXXX XXXXXX . Genky Drug Stores acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Genky Drug Stores founded? | Genky Drug Stores was founded in 1990. |
| Where is Genky Drug Stores headquartered? | Genky Drug Stores is headquartered in Japan. |
| How many employees does Genky Drug Stores have? | As of today, Genky Drug Stores has 2.8K+ employees. |
| Is Genky Drug Stores publicy listed? | Yes, Genky Drug Stores is a public company listed on TKS. |
| What is the stock symbol of Genky Drug Stores? | Genky Drug Stores trades under 9267 ticker. |
| When did Genky Drug Stores go public? | Genky Drug Stores went public in 2010. |
| Who are competitors of Genky Drug Stores? | Similar companies to Genky Drug Stores include e.g. MedPlus India, Pague Menos, Droga Raia, Redcare Pharmacy. |
| What is the current market cap of Genky Drug Stores? | Genky Drug Stores's current market cap is $597M |
| What is the current revenue of Genky Drug Stores? | Genky Drug Stores's last 12-month revenue is $1.3B. |
| What is the current EV/Revenue multiple of Genky Drug Stores? | Current revenue multiple of Genky Drug Stores is 0.6x. |
| What is the current revenue growth of Genky Drug Stores? | Genky Drug Stores revenue growth between 2023 and 2024 was 9%. |
| Is Genky Drug Stores profitable? | Yes, Genky Drug Stores is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
